Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. - Pastor M; Fernández-Calle R; Di Geronimo B; Vicente-Rodríguez M; Zapico JM; Gramage E; Coderch C; Pérez-García C; Lasek AW; Puchades-Carrasco L; Pineda-Lucena A; de Pascual-Teresa B; et al. (European journal of medicinal chemistry, 2018)